Cited by 153Alzheimer's disease research and treatmentsRetinal Diseases and TreatmentsDementia and Cognitive Impairment Research

Ocular changes in TgF344-AD rat model of Alzheimer's disease

Open access
Tsai, Yuchun, Lu, Bin, Ljubimov, Alexander V., Girman, Sergey, Ross-Cisneros, Fred N., Sadun, Alfredo A., Svendsen, Clive N., Cohen, Robert M. +1 more·2014·Investigative Opthalmology & Visual Science

Abstract

PURPOSE: Alzheimer's disease (AD) is the most common neurodegenerative disorder characterized by progressive decline in learning, memory, and executive functions. In addition to cognitive and behavioral deficits, vision disturbances have been reported in early stage of AD, well before the diagnosis is clearly established. To further investigate ocular abnormalities, a novel AD transgenic rat model was analyzed. METHODS: Transgenic (Tg) rats (TgF344-AD) heterozygous for human mutant APPswe/PS1ΔE9 and age-matched wild type (WT) rats, as well as 20 human postmortem retinal samples from both AD and healthy donors were used. Visual function in the rodent was analyzed using the optokinetic response and luminance threshold recording from the superior colliculus. Immunohistochemistry on retinal and brain sections was used to detect various markers including amyloid-β (Aβ) plaques. RESULTS: As expected, Aβ plaques were detected in the hippocampus, cortex, and retina of Tg rats. Plaque-like structures were also found in two AD human whole-mount retinas. The choroidal thickness was significantly reduced in both Tg rat and in AD human eyes when compared with age-matched controls. Tg rat eyes also showed hypertrophic retinal pigment epithelial cells, inflammatory cells, and upregulation of complement factor C3. Although visual acuity was lower in Tg than in WT rats, there was no significant difference in the retinal ganglion cell number and retinal vasculature. CONCLUSIONS: In this study, we observed pathological changes in the choroid and in RPE cells in the TgF344-AD rat model; choroidal thinning was observed further in human AD retina. Along with Ab deposition, the inflammatory response was manifested by microglial recruitment and complement activation. Further studies are needed to elucidate the significance and mechanisms of these pathological changes [corrected].

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1167/iovs.13-12888

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In TgF344-AD transgenic rat model, Aβ deposition, microglial recruitment, and complement activation are associated with decline in visual function.

    “In the transgenic rat model (TgF344-AD) also has been observed, along with Aβ deposition, microglial recruitment, and complement activation in association with a decline in visual function (Tsai et al., 2014; Table 1).”
  • Abundant evidence from animal and clinical studies shows a correlation between ocular pathology and AD development.

    “Abundant evidence from animal and clinical studies shows a correlation between ocular pathology and AD development.553–555”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 99 · Cited by 153

Research works printed but not linked: 2

  1. Liu B, Rasool S, Yang Z, et al. Amyloid-peptide vaccinations reduce beta-amyloid plaques but exacerbate vascular deposi- tion and inflammation in the retina of Alzheimer's transgenic mice. Am J Pathol. 2009;175:2099-2110.
  2. Querques G, Lattanzio R, Querques L, et al. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci. 2012;53:6017-6024.

Authors
Tsai, Y., Lu, B., Ljubimov, A. V., Girman, S., Ross-Cisneros, F. N., Sadun, A. A., Svendsen, C. N., Cohen, R. M., & Wang, S.
Affiliations
  • Cedars-Sinai Regenerative Medicine Institute, Los Angeles, California
  • University of California, Los Angeles (US)
  • Cedars-Sinai Medical Center (US)
  • Doheny Eye Institute and Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles, California
  • University of Southern California (US)
  • Emory University (US)
Corresponding author
Wang, Shaomei
Venue
Investigative Opthalmology & Visual Science
Published
2014-01-29
Volume
55
Issue
1
Pages
523
ISSN
  • 0146-0404 (ISSN-L)
  • 1552-5783
OpenAlex
W1975040154
Cited by
153
References
99
Citations by year
2026: 2 · 2025: 17 · 2024: 5 · 2023: 7 · 2022: 17 · 2021: 17 · 2020: 20 · 2019: 14 · 2018: 15 · 2017: 10 · 2016: 15 · 2015: 9 · 2014: 5
FWCI
8.64
Type
journal article
Language
en
Open access
Locations
  • Investigative Ophthalmology & Visual Science (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Department of Defense (W81XWH)
  • University of Southern California
  • Lincy Foundation
  • Cedars-Sinai Medical Center
  • National Institutes of Health (NIH-R01, W81XWH, AG05142, EY-03040)
  • National Institute on Aging (P50-AG05142, P50AG005142)
  • National Eye Institute (P30EY003040, R01-EY-03040, R01EY020488)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
Alzheimer's disease, TgF344-AD rat model, choroidal thinning, complement C3, microglial inflammation, visual function, optokinetic response, superior colliculus, visual acuity
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Amyloid, Animals, Cell Count, Choroid, Disease Models, Animal, Female, Humans, Immunohistochemistry, Male, Middle Aged, Rats, Inbred F344, Retinal Diseases, Visual Acuity, Rats, Retinal Pigment Epithelium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review